Moreover, the expression of PD-L1 detected by IHC or mRNA was significantly lower in EGFR-MT NSCLC than in the wild types as revealed in a large number of clinical trials (25, 38, 61). This evidence concerns the gene EGFR and non-small cell lung carcinoma.